Monopar Therapeutics
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Mailing Address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Phone
8473880349
Fiscal Year End
1231
EIN
320463781
Financial Overview
FY2025
$137.83M
Stockholders' Equity
$45.82M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 4 Insider stock transaction report | April 2, 2026 | View on SEC |
| 10-K/A Annual report amendment | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 10-K Annual financial report | March 27, 2026 | View on SEC |
| 3 Initial insider ownership report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 6, 2026 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Advancing clinical-stage pipeline including MNPR-101 for advanced cancers and ALXN1840 for Wilson disease.
- Established internal research capabilities with a new 10,000-square-foot laboratory in North Chicago.
Insider Trading
SELL
2 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.